Association between ibrutinib treatment and hypertension.

Dae Hyun LeeFahad HawkKieun SeokMatthew GliksmanJosephine EmoleIsaac B RheaFederico ViganegoAllan Welter-FrostMerna ArmaniousBijal ShahJuliio C ChavezJavier Pinilla-IbarzMatthew B SchabathMichael G Fradley

Published in: Heart (British Cardiac Society) (2021)

Ibrutinib is associated with the development of hypertension and worsening of blood pressure. Cardiologists and oncologists must be aware of this cardiotoxicity to allow timely management of blood pressure elevations.

Keyphrases

blood pressure
hypertensive patients
heart rate
chronic lymphocytic leukemia
type diabetes
combination therapy
palliative care
skeletal muscle